Fatma A. Taha1,2,*, Osama Amoudi1, Fareed Alnozha1, Reda Abuelatta1
Congenital Heart Disease, Vol.17, No.4, pp. 399-419, 2022, DOI:10.32604/chd.2022.020174
- 04 July 2022
Abstract Background: Adult patients with congenital heart disease (ACHD) might be at high risk of Coronavirus disease-
2019 (COVID-19). This study aimed to report on a one-year tertiary center experience regards COVID-19 infection in ACHD patients. Methods: This is a one-year (March-2020 to March-2021) tertiary-center retrospective
study that enrolled all ACHD patients; COVID-19 positive patients’ medical records, and management were
reported. Results: We recorded 542 patients, 205 (37.8%) COVID-19-positive, and 337 (62.2%) COVID-19-negative
patients. Palliated single ventricle and Eisenmenger syndrome patients were more vulnerable to COVID-19 infection
(P < 0.05*). Cardiovascular COVID-19 complications were arrhythmias in 47 (22.9%)… More >
Login
Register
